SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-282575
Filing Date
2022-11-10
Accepted
2022-11-10 16:07:09
Documents
12
Period of Report
2022-11-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K d319315d8k.htm   iXBRL 8-K 31809
  Complete submission text file 0001193125-22-282575.txt   162536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bior-20221110.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20221110_lab.xml EX-101.LAB 19484
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20221110_pre.xml EX-101.PRE 12167
6 EXTRACTED XBRL INSTANCE DOCUMENT d319315d8k_htm.xml XML 3686
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 221377104
SIC: 2834 Pharmaceutical Preparations